Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Jun 2026 for Aurinia Pharmaceuticals Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Tang Capital Management, LLC: trading record in brief
All filings by Tang Capital Management, LLC on record concern Aurinia Pharmaceuticals Inc. Activity is concentrated on a single trading day, 2 June 2026, with 6 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 12 June 2026: a transaction, in Aurinia Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 10 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Tang Capital Management, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
OptionsTSXSEDI:4734885
OptionsTSXSEDI:4734884
Common SharesTSXSEDI:4734882
Common SharesTSXSEDI:4734881
Common SharesTSXSEDI:4734879
Common SharesTSXSEDI:4734876
6 of 6 declarations
